Selected research
Industry Growth & Trends
Global Radiopharmaceuticals for Therapeutic Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Radiopharmaceuticals for Therapeutic market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Radiopharmaceuticals for Therapeutic is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Radiopharmaceuticals for Therapeutic is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Radiopharmaceuticals for Therapeutic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Radiopharmaceuticals for Therapeutic market include Novartis, Bayer, Q BioMed, Mundipharma, Lantheus, Jubilant Radiopharma, International Isotopes, Dongcheng and Curium Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Radiopharmaceuticals for Therapeutic market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Radiopharmaceuticals for Therapeutic market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Radiopharmaceuticals for Therapeutic market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Radiopharmaceuticals for Therapeutic.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Radiopharmaceuticals for Therapeutic market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Radiopharmaceuticals for Therapeutic Market by Company
Novartis
Bayer
Q BioMed
Mundipharma
Lantheus
Jubilant Radiopharma
International Isotopes
Dongcheng
Curium Pharmaceuticals
China Isotope & Radiation
Aurobindo Pharma
Radiopharmaceuticals for Therapeutic Segment by Type
Radium-223
Lutetium-177
Iodine-131
Other
Radiopharmaceuticals for Therapeutic Segment by Application
Lymphoma
Thyroid
Bone Metastasis
Other
Radiopharmaceuticals for Therapeutic Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceuticals for Therapeutic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceuticals for Therapeutic and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceuticals for Therapeutic.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Radiopharmaceuticals for Therapeutic companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Radium-223
- Lutetium-177
- Iodine-131
- Other
Applications
- Lymphoma
- Thyroid
- Bone Metastasis
- Other
Companies covered
- Novartis
- Bayer
- Q BioMed
- Mundipharma
- Lantheus
- Jubilant Radiopharma
- International Isotopes
- Dongcheng
- Curium Pharmaceuticals
- China Isotope & Radiation
- Aurobindo Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Radiopharmaceuticals for Therapeutic Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Radiopharmaceuticals for Therapeutic Market Size by Region (2021-2032)
- 1.4.1 Global Radiopharmaceuticals for Therapeutic Market Size by Region (2021-2026)
- 1.4.2 Global Radiopharmaceuticals for Therapeutic Market Size by Region (2027-2032)
- 1.5 Key Regions Radiopharmaceuticals for Therapeutic Market Size (2021-2032)
- 1.5.1 North America Radiopharmaceuticals for Therapeutic Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Radiopharmaceuticals for Therapeutic Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Radiopharmaceuticals for Therapeutic Market Size Growth Rate (2021-2032)
- 1.5.4 South America Radiopharmaceuticals for Therapeutic Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size Growth Rate (2021-2032)
2 Radiopharmaceuticals for Therapeutic Market by Type
- 2.1 Type Introduction
- 2.1.1 Radium-223
- 2.1.2 Lutetium-177
- 2.1.3 Iodine-131
- 2.1.4 Other
- 2.2 Global Radiopharmaceuticals for Therapeutic Market Size by Type
- 2.2.1 Global Radiopharmaceuticals for Therapeutic Market Size Overview by Type (2021-2032)
- 2.2.2 Global Radiopharmaceuticals for Therapeutic Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Radiopharmaceuticals for Therapeutic Market Size Forecasted by Type (2027-2032)
- 2.3 Global Radiopharmaceuticals for Therapeutic Market Size by Regions
- 2.3.1 North America Radiopharmaceuticals for Therapeutic Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Radiopharmaceuticals for Therapeutic Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Radiopharmaceuticals for Therapeutic Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Radiopharmaceuticals for Therapeutic Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Radiopharmaceuticals for Therapeutic Market Size Breakdown by Type (2021-2026)
3 Radiopharmaceuticals for Therapeutic Market by Application
- 3.1 Type Introduction
- 3.1.1 Lymphoma
- 3.1.2 Thyroid
- 3.1.3 Bone Metastasis
- 3.1.4 Other
- 3.2 Global Radiopharmaceuticals for Therapeutic Market Size by Application
- 3.2.1 Global Radiopharmaceuticals for Therapeutic Market Size Overview by Application (2021-2032)
- 3.2.2 Global Radiopharmaceuticals for Therapeutic Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Radiopharmaceuticals for Therapeutic Market Size Forecasted by Application (2027-2032)
- 3.3 Global Radiopharmaceuticals for Therapeutic Market Size by Regions
- 3.3.1 North America Radiopharmaceuticals for Therapeutic Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Radiopharmaceuticals for Therapeutic Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Radiopharmaceuticals for Therapeutic Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Radiopharmaceuticals for Therapeutic Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Radiopharmaceuticals for Therapeutic Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Radiopharmaceuticals for Therapeutic Industry Trends
- 4.2 Radiopharmaceuticals for Therapeutic Industry Drivers
- 4.3 Radiopharmaceuticals for Therapeutic Industry Opportunities and Challenges
- 4.4 Radiopharmaceuticals for Therapeutic Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Radiopharmaceuticals for Therapeutic Revenue (2021-2026)
- 5.2 Global Radiopharmaceuticals for Therapeutic Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Radiopharmaceuticals for Therapeutic Key Company Headquarters & Area Served
- 5.4 Global Radiopharmaceuticals for Therapeutic Company, Product Type & Application
- 5.5 Global Radiopharmaceuticals for Therapeutic Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Radiopharmaceuticals for Therapeutic Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Radiopharmaceuticals for Therapeutic Players Market Share by Revenue in 2025
- 5.6.3 2025 Radiopharmaceuticals for Therapeutic Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Novartis
- 6.1.1 Novartis Company Information
- 6.1.2 Novartis Business Overview
- 6.1.3 Novartis Radiopharmaceuticals for Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Novartis Radiopharmaceuticals for Therapeutic Product Portfolio
- 6.1.5 Novartis Recent Developments
- 6.2 Bayer
- 6.2.1 Bayer Company Information
- 6.2.2 Bayer Business Overview
- 6.2.3 Bayer Radiopharmaceuticals for Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Bayer Radiopharmaceuticals for Therapeutic Product Portfolio
- 6.2.5 Bayer Recent Developments
- 6.3 Q BioMed
- 6.3.1 Q BioMed Company Information
- 6.3.2 Q BioMed Business Overview
- 6.3.3 Q BioMed Radiopharmaceuticals for Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Q BioMed Radiopharmaceuticals for Therapeutic Product Portfolio
- 6.3.5 Q BioMed Recent Developments
- 6.4 Mundipharma
- 6.4.1 Mundipharma Company Information
- 6.4.2 Mundipharma Business Overview
- 6.4.3 Mundipharma Radiopharmaceuticals for Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Mundipharma Radiopharmaceuticals for Therapeutic Product Portfolio
- 6.4.5 Mundipharma Recent Developments
- 6.5 Lantheus
- 6.5.1 Lantheus Company Information
- 6.5.2 Lantheus Business Overview
- 6.5.3 Lantheus Radiopharmaceuticals for Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Lantheus Radiopharmaceuticals for Therapeutic Product Portfolio
- 6.5.5 Lantheus Recent Developments
- 6.6 Jubilant Radiopharma
- 6.6.1 Jubilant Radiopharma Company Information
- 6.6.2 Jubilant Radiopharma Business Overview
- 6.6.3 Jubilant Radiopharma Radiopharmaceuticals for Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Jubilant Radiopharma Radiopharmaceuticals for Therapeutic Product Portfolio
- 6.6.5 Jubilant Radiopharma Recent Developments
- 6.7 International Isotopes
- 6.7.1 International Isotopes Company Information
- 6.7.2 International Isotopes Business Overview
- 6.7.3 International Isotopes Radiopharmaceuticals for Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 International Isotopes Radiopharmaceuticals for Therapeutic Product Portfolio
- 6.7.5 International Isotopes Recent Developments
- 6.8 Dongcheng
- 6.8.1 Dongcheng Company Information
- 6.8.2 Dongcheng Business Overview
- 6.8.3 Dongcheng Radiopharmaceuticals for Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Dongcheng Radiopharmaceuticals for Therapeutic Product Portfolio
- 6.8.5 Dongcheng Recent Developments
- 6.9 Curium Pharmaceuticals
- 6.9.1 Curium Pharmaceuticals Company Information
- 6.9.2 Curium Pharmaceuticals Business Overview
- 6.9.3 Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Product Portfolio
- 6.9.5 Curium Pharmaceuticals Recent Developments
- 6.10 China Isotope & Radiation
- 6.10.1 China Isotope & Radiation Company Information
- 6.10.2 China Isotope & Radiation Business Overview
- 6.10.3 China Isotope & Radiation Radiopharmaceuticals for Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 China Isotope & Radiation Radiopharmaceuticals for Therapeutic Product Portfolio
- 6.10.5 China Isotope & Radiation Recent Developments
- 6.11 Aurobindo Pharma
- 6.11.1 Aurobindo Pharma Company Information
- 6.11.2 Aurobindo Pharma Business Overview
- 6.11.3 Aurobindo Pharma Radiopharmaceuticals for Therapeutic Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Aurobindo Pharma Radiopharmaceuticals for Therapeutic Product Portfolio
- 6.11.5 Aurobindo Pharma Recent Developments
7 North America
- 7.1 North America Radiopharmaceuticals for Therapeutic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Radiopharmaceuticals for Therapeutic Market Size by Country (2021-2026)
- 7.3 North America Radiopharmaceuticals for Therapeutic Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Radiopharmaceuticals for Therapeutic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Radiopharmaceuticals for Therapeutic Market Size by Country (2021-2026)
- 8.3 Europe Radiopharmaceuticals for Therapeutic Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Radiopharmaceuticals for Therapeutic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Radiopharmaceuticals for Therapeutic Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Radiopharmaceuticals for Therapeutic Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Radiopharmaceuticals for Therapeutic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Radiopharmaceuticals for Therapeutic Market Size by Country (2021-2026)
- 10.3 South America Radiopharmaceuticals for Therapeutic Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Radiopharmaceuticals for Therapeutic Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst